). Like other BH3-only proteins, PUMA induces apoptosis by binding to the prosurvival members of the Bcl-2 family, for example, Bcl-2, Bcl-x, Mcl-1, thereby relieving the inhibitory effect of the prosurvival proteins on the proapoptotic proteins, Bax and Bak. This results in activation of Bax and Bak, subsequent release of cytochrome c from the mitochondria, and ultimately, cell death. For example, DNA damage caused by ionizing radiation results in the accumulation and activation of p53, which upregulates puma transcription. Newly synthesized PUMA is then able to antagonize Bcl-2 family prosurvival proteins resulting in the activation of Bax and Bak and eventual cell death.
Although it was initially proposed that p53 acts solely in the nucleus to transactivate genes such as puma to induce cell death, a recent report by Chipuk et al. 5 proposed an additional, radically different role for p53 in PUMA-mediated apoptosis. In this model, p53 is not only needed to transactivate puma, it must also accumulate in the cytoplasm, where it initially binds to Bcl-x. As the level of PUMA rises, it displaces p53 from Bcl-x. Liberated p53 is then able to bind and activate Bax, thereby inducing mitochondrial outer membrane permeabilization and cytochrome c release leading to cell death.
According to this model, PUMA is unable to induce cell death in the absence of p53. Indeed, Chipuk et al. 5 stated that 'PUMA is not sufficient for apoptosis or sensitization to UVinduced apoptosis in the absence of p53,' and consistent with this, they found that puma expression did not cause apoptosis in HCT116 p53 À/À cells, or sensitize them to apoptosis after exposure to UV.
To verify this model, in which cytoplasmic p53 is required for PUMA-mediated apoptosis, we used a 4-hydroxy tamoxifen (4HT)-inducible lentiviral system to express wild-type PUMA in p53 À/À cells ( Figure 1a ). Using this system we generated 4HT-inducible PUMA lines of mouse embryonic fibroblasts These results are not consistent with a mechanism in which PUMA acts by liberating p53 from Bcl-x so that it can bind and activate Bax on the mitochondria, but support a model in which p53 is solely required for the transcriptional activation of puma following irradiation.
Although our experiments were in MEFs and IL-3-dependent myeloid cell lines, whereas Chipuk et al. examined HCT116 cells, the differences in requirement for p53 are not likely to be due to cell type, because other investigators have looked at the effects of PUMA expression in other p53 WT, mutant and null cell lines. For example, the Vousden and Vogelstein laboratories reported that PUMA expression was sufficient to cause apoptosis in several p53 mutant cell lines. Our results demonstrate that PUMA can cause apoptosis independently of p53 in both p53 null fibroblasts and in p53 null IL-3-dependent myeloid cell lines, and are consistent with earlier observations both in WT and p53 À/À HCT116 cells and in several other p53 mutant cell lines. 1, 2 Several studies using cells from puma-deficient mice have also implicated PUMA in forms of apoptosis known to be p53-independent, namely that caused by cytokine withdrawal or treatment with dexamethasone. 3, [6] [7] [8] [9] Collectively these results indicate that PUMA can cause apoptosis in the absence of p53. Although we did not investigate whether cytosolic p53 can directly activate Bax to induce cell death, it is clear that once puma is transactivated by p53, there is no requirement for cytoplasmic p53 for PUMA to cause apoptosis. À/À MEFs were generated by lentiviral infection. Expression of PUMA or GFP was induced where indicated ( þ ) with 100 nM 4HT. After 24 h, flow cytometry was used to measure plasma membrane integrity by propidium iodide (PI) exclusion. Expression of PUMA resulted in loss of MEF viability whereas induction of GFP had no effect. The numbers 1 and 3 refer to MEFs derived from independent p53 À/À embryos. (c) Cumulative data for the experiments described in (b) as determined at 24 and 48 h ± 4HT. The data is presented as mean ± S.E.M from three independent experiments. (d) PUMA expression was induced by 1 mM 4HT in IL-3-dependent p53
þ /À and p53 À/À cells. Cell viability was assessed after 24 h by staining with annexin V and PI. PUMA caused the same amount of cell death whether cells were heterozygous or homozygous mutant for p53. (e) Cumulative data for the experiments described in (d). For PUMA, cell viabilities are presented as the mean ± S.E.M. from multiple independent experiments using several clones of p53 þ /À (n ¼ 5) or p53 À/À (n ¼ 6) cells derived from two independent embryos of each genotype. As a control, GFP was also expressed in four independent clones of p53 À/À cells derived from two independent embryos. Similar results were obtained by expressing PUMA in NIH3T3 cells and independently derived WT MEFs (data not shown)
